Osiedle Radosna Doctor Q BUD Spółka z Ograniczoną Odpowiedzialnością Spółka Komandytowa (KRS 0000896470, NIP 6762595963) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. OSIEDLE RADOSNA DOCTOR Q BUD SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ operates in: Development of building projects (PKD 41.10.Z). Industry: Building construction. The company has been listed in the National Court Register since April 23, 2021.
Negative equity
Negative equity in 1 of 3 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Osiedle Radosna Doctor Q BUD
Identity
- Name
- Osiedle Radosna Doctor Q BUD Spółka z Ograniczoną Odpowiedzialnością Spółka Komandytowa
- Legal form
- SPÓŁKA KOMANDYTOWA
- Founded
- April 23, 2021
- Registry status as of
- May 12, 2026
- Latest entry
- May 12, 2026
- Founding act
- 20.04.2021
Articles of association history (1)
- April 20, 2021: 20.04.2021
Activities
Address and contact
- Address
- PLAC NA GROBLACH, 5, 42, 31-101, KRAKÓW, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKÓW
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Osiedle Radosna Doctor Q BUD
Credibility rating
9.4 / 100
Very poor credibility
Insolvency risk
Very high
Significant formal threat
Closure risk
35
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/5 yrs
Board changes
0
0/5 yrs
PKD changes
0
0/5 yrs
Name changes
0
0/5 yrs
Data from 5 years of registry activity.
Credibility history
Payment reliability score from 2021–2023
Current: E (9/100)
Trend: deteriorating (-22.3 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2021–2023
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Osiedle Radosna Doctor Q BUD
Founded
April 23, 2021
5 years in operation
Legal form
SPÓŁKA KOMANDYTOWA
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
41.10.Z
Development of building projects
Share capital
N/A
Shareholders
N/A
Board
N/A
Filed years
3 years
2021–2023 · profitable: 0/3
Registry entries
15
latest: May 12, 2026
Risk signals
Revenue
N/A
2023
Net profit
-281 PLN
2023
Assets
200 PLN
2023
Equity
-81 PLN
2023
EBITDA
N/A
2023
no depreciation data
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Osiedle Radosna Doctor Q BUD.
No ratings
Related articles
News
Archicom: PLN 1.80 per share dividend recommendation after a record 2025 - 2,847 apartments sold, 3x the market growth
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.
News
Atal: PLN 4.50 per share dividend recommendation (88% payout) - ~8.6% yield, one of the highest in the Polish residential-developer sWIG80
Cieszyn-based Atal S.A. (KRS 0000262397) closed 2025 with revenue of PLN 1.267 bn, net profit of PLN 223.3 m and a 17.6% net margin. The board recommends a PLN 4.50 per share dividend (88% of profit, PLN 194.67 m in total, ~8.6% yield) - lower than the PLN 6.00 paid out of 2024 but still among the highest in the Polish residential-developer sector. Q1 2026 saw handovers double (500 vs 218 YoY); 2026 targets are 2,500-3,000 sold and 3,000-4,000 handed over. Juroszek Holding control: 76.30% of capital.
